Pfizer's Sandwich site to be enterprise zone; Endo sues Mylan over generic Frova;

@FiercePharma: Antipsychotics beat mood stabilizers for manic episodes, with generic Haldol in first place. Zyprexa, Risperdal next. Story | Follow @FiercePharma

> The U.K. government has officially designated Pfizer's research site in Sandwich as an enterprise zone to help boost development there as the drugmaker pulls most of its operations out. Item | Report

> Endo Pharmaceuticals sued Mylan to bar the generic maker's attempts to make and sell a copycat version of its migraine drug Frova. Story

> Blood-derived therapies maker CSL failed to meet analyst expectations with an 11% decline in annual profits, hurt by the Australian dollar's strength. Article

> Spending on AIDS fell in 2010 for the first time since U.S. and other governments began providing significant funding. More

> Belgium's Omega Pharma is in the final stages of its plan to delist, lacking approval from only a couple of lenders. News

> A new research review found no evidence that women who take aspirin daily have better success with in-vitro fertilization. Report

Biotech News

@FierceBiotech: PhRMA demands an overhaul of FDA's regs on drug names. Report | Follow @FierceBiotech

@JohnCFierce: Cytos hits the wall; laying off most of its workers, circling wagons on lead program. News | Follow @JohnCFierce

@RyanMFierce: A source in small-medium U.S. biopharma has told me taking the trip to meet offshore investigators for trials is well worth the time & money. Follow @RyanMFierce

@MaureenFierce: 11 Biotech Stocks Loved or Hated by Hedge Funds. List | Follow @MaureenFierce

> Roche to hire 200 R&D staffers for new global development center. News

> Updated: Cytos shares nosedive as funding crisis triggers layoffs, R&D halt. Report

> Roche wins early approval for blockbuster melanoma drug vemurafenib. Item 

Drug Delivery News

> "Nanolids" keep meds bottled up until ready for release into tumors. Report

> Microscale gelatin mold can cook up drug-delivering particles. More

> Drug-eluting sinus implant gets FDA premarket approval. Article

> Molecular "Fed-Ex truck" knocks down mutant proteins, delivers genes. Details

> Osmotica's Georgia expansion shows there are jobs in drug delivery. News

> June deals a snapshot of drug-delivery trends. Story

Medical Device News

> AngioDynamics taps DeVivo as CEO. More

> QIAGEN, Pfizer team up on companion diagnostic. Report

> EO2 Concepts looks for a better way to treat wounds. Story

> Ex-Competitive Technologies CEO gets his money. News

> Revolutions Medical gets win against Globe. Details

> Abbott's BVS used in first patient in Japan. Article

And Finally... Every hour of TV watched after the age of 25 reduces life expectancy by 21 minutes on average. Article